Synthesis of antibacterial aminoglycoside analogs
The present disclosure relates to novel methods for preparing antibacterial aminoglycoside compounds, as well as to related intermediates, and crystal forms thereof, useful in such methods.
1. A process for preparing a compound of formula (2), or a salt thereof, or solvate thereof, or an enantiomer thereof, or a diastereomer thereof comprising:
(a) contacting a compound of formula (1):
or an enantiomer thereof, or a diastereomer thereof, with 1-{[(p-nitrobenzyl)oxy]carbonyl}-1H-benzotriazole (PNZ-Bt) to form the compound of formula (2):
or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof;
wherein - - - is a single bond or a double bond;
R 1 is H or C 1 -C 3 alkyl;
R 2 is H or C 1 -C 3 alkyl; and
R 3 is H or C 1 -C 3 alkyl.
2. The process of claim 1 , wherein step (a) is performed in the presence of a solvent selected from the group consisting of dichloromethane, methanol, and a combination thereof.
3. The process of claim 1 , further comprising step (b1) or (b2):
(b1) wherein when R 1 , R 2 , and R 3 are H, contacting the compound of formula (2) with a Boc protecting group reagent to yield a compound of formula (3):
or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof; or
(b2) wherein when one or more of R 1 , R 2 , or R 3 is independently a C 1 -C 3 alkyl, first removing said C 1 -C 3 alkyl, and then contacting the compound of formula (2), or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof, with a Boc protecting group reagent to yield a compound of formula (3):
or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof.
4. The process of claim 3 , wherein step (b1) or (b2) is performed in the presence of a Lewis acid.
5. The process of claim 3 , further comprising:
(c) contacting the compound of formula (3), or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof, with
to yield a compound of formula (4):
or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof.
6. The process of claim 5 , wherein step (c) is performed in the presence of an activating reagent and a peptide coupling reagent.
7. The process of claim 5 , wherein step (c) is performed in an acidic condition.
8. The process of claim 5 , further comprising preparing a crystalline form of compound of formula (4), or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof.
9. The process of claim 5 , further comprising:
(d) contacting the compound of formula (4), or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof, with Boc protecting group reagent to yield a compound of formula (5):
or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof.
10. The process of claim 9 , wherein step (d) is performed in the presence of an alcohol.
11. The process of claim 9 , further comprising:
(e) contacting the compound of formula (5), or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof, with a PNZ deprotecting reagent to yield a compound of formula (6):
or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof; and
further comprising preparing a crystalline form of compound of formula (6), or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof.
12. The process of claim 11 , further comprising:
(f) contacting the compound of formula (6), or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof, with
wherein LG 1 is a leaving group, to yield a compound of formula (7):
or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof.
13. The process of claim 12 , further comprising:
(g) contacting the compound of formula (7), or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof, with a Boc removing reagent to yield a compound of formula (8):
or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof; and
(h) performing a salt formation with an acid to yield a salt of a compound of formula (8), or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof.
14. The process of claim 13 , wherein the Boc removing reagent is TFA, thereby yielding a TFA salt of compound of formula (8), or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof; and
(h) performing a salt formation with an acid to yield a salt of a compound of formula (8), or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof.
15. The process of claim 1 , wherein - - - is a double bond.
16. The process of claim 1 , wherein the stereochemistry at carbon atoms 1, 3, 4, 5, 6, 1′, 2′, 1″, 2″, 3″, and 4″ in formulae (1)-(3) are indicated as in formula (X), wherein indicates a point of attachment to hydrogen or a moiety:
17. The process of claim 14 , wherein the acid in step (h) is sulfuric acid, thereby yielding a sulfate salt of a compound of formula (9):
or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof, wherein x is 1 to 5.